Recent Progress in Genetics and Epigenetics Research on Diabetic Nephropathy in Malaysia

Diabetic nephropathy is a multifactorial disease. Gene susceptibility, as well as environmental exposure, plays an important role in disease progression. Malaysia is reported to be among the world's second-fastest-growing rates of kidney failure. Diabetic nephropathy has become the main cause of end-stage renal disease in Malaysia. This article is aimed at reviewing genetic studies conducted among diabetic nephropathy patients in the Malaysian population. This review was conducted by searching PubMed, MEDLINE, and Google Scholar databases to identify all relevant papers published in English from March 2022 to April 2022, using the following keywords: diabetes, type 2 diabetes, diabetic nephropathy, diabetic kidney disease, and Malaysia. The case-control study among diabetic patients with and without diabetic nephropathy showed a significant association with diabetic nephropathy in CNDP1, NOS3, and MnSOD genes. In the ethnic subgroup analysis, significant differences for diabetic nephropathy in terms of diabetes duration (≥10 years) were observed for CCL2 rs3917887, CCR5 rs1799987, ELMO1 rs74130, and IL8 rs4073. The IL8 rs4073 was associated only with the Indians, while the CCR5 rs1799987 was associated with the Chinese. In Malays, SLC12A3 Arg913Gln polymorphism and ICAM1 K469E (A/G) polymorphism were found to be associated with diabetic nephropathy. Studies on gene-environment interactions have suggested significant genetic and environmental factors such as smoking, waist circumference, and sex for eNOS rs2070744, PPARGC1A rs8192678, KCNQ1 rs2237895, and KCNQ1 rs2283228 with kidney disease. The genetic variants' contributions differed across ethnic groups. Therefore, a study to validate the genetic variants that are found to be associated with different ethnicities in Malaysia may be important in future studies.

[1]  D. Moczulski,et al.  Association of chemotactic cytokine receptor 5 (CCR5) gene polymorphism (59029 A/G, rs1799987) with diabetic kidney disease in patients with type 2 diabetes from Poland. , 2022, Endokrynologia Polska.

[2]  Jinwen Wu,et al.  Association between polymorphisms of cytokine genes and diabetic nephropathy: A comprehensive systematic review and meta‐analysis , 2021, International journal of clinical practice.

[3]  H. Gupta,et al.  Association of eNOS and MCP-1 Genetic Variants with Type 2 Diabetes and Diabetic Nephropathy Susceptibility: A Case–Control and Meta-Analysis Study , 2021, Biochemical Genetics.

[4]  M. Serdar,et al.  Sample size, power and effect size revisited: simplified and practical approaches in pre-clinical, clinical and laboratory studies , 2020, Biochemia medica.

[5]  T. Aris,et al.  Prevalence of chronic kidney disease and its associated factors in Malaysia; findings from a nationwide population-based cross-sectional study , 2020, BMC Nephrology.

[6]  H. Zhao,et al.  The single nucleotide polymorphism rs11643718 in SLC12A3 is associated with the development of diabetic kidney disease in Chinese people with type 2 diabetes , 2020, Diabetic medicine : a journal of the British Diabetic Association.

[7]  N. A. Abdul Murad,et al.  Gene‐environment interaction in chronic kidney disease among people with type 2 diabetes from The Malaysian Cohort project: a case‐control study , 2020, Diabetic medicine : a journal of the British Diabetic Association.

[8]  S. Jiménez-Morales,et al.  Arg913Gln variation of SLC12A3 gene is associated with diabetic nephropathy in type 2 diabetes and Gitelman syndrome: a systematic review , 2019, BMC Nephrology.

[9]  Ian McQuillan,et al.  Size matters: how sample size affects the reproducibility and specificity of gene set analysis , 2019, Human Genomics.

[10]  P. Ismail,et al.  CNDP1, NOS3, and MnSOD Polymorphisms as Risk Factors for Diabetic Nephropathy among Type 2 Diabetic Patients in Malaysia , 2019, Journal of nutrition and metabolism.

[11]  P. Ismail,et al.  Association of CCL2, CCR5, ELMO1, and IL8 Polymorphism with Diabetic Nephropathy in Malaysian Type 2 Diabetic Patients , 2019, International journal of chronic diseases.

[12]  V. Mohan,et al.  Association of rs11643718 SLC12A3 and rs741301 ELMO1 Variants with Diabetic Nephropathy in South Indian Population , 2016, Annals of human genetics.

[13]  Marc Tessier-Lavigne,et al.  Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9 , 2016, Nature.

[14]  C. Östenson,et al.  Genetic, epigenetic and protein analyses of intercellular adhesion molecule 1 in Malaysian subjects with type 2 diabetes and diabetic nephropathy. , 2015, Journal of diabetes and its complications.

[15]  C. Östenson,et al.  Increased DNA methylation of the SLC30A8 gene promoter is associated with type 2 diabetes in a Malay population , 2015, Clinical Epigenetics.

[16]  Wan Nazaimoon wan Mohamud,et al.  Genetic and Biological Effects of Sodium-Chloride Cotransporter (SLC12A3) in Diabetic Nephropathy , 2014, American Journal of Nephrology.

[17]  M. Ishaq,et al.  Polymorphisms in oxidative stress pathway genes and risk of diabetic nephropathy in South Indian type 2 diabetic patients , 2014, Nephrology.

[18]  A. Khan,et al.  Association of the endothelial nitric oxide synthase gene G894T polymorphism with the risk of diabetic nephropathy in Qassim region, Saudi Arabia—A pilot study , 2014, Meta gene.

[19]  D. Ye,et al.  D18S880 microsatellite polymorphism of carnosinase gene and diabetic nephropathy: a meta-analysis. , 2013, Genetic testing and molecular biomarkers.

[20]  C. Ling,et al.  Identification of CpG-SNPs associated with type 2 diabetes and differential DNA methylation in human pancreatic islets , 2013, Diabetologia.

[21]  M. Ismail,et al.  Endothelial nitric oxide synthase gene polymorphisms and the risk of diabetic nephropathy in type 2 diabetes mellitus. , 2012, Genetic testing and molecular biomarkers.

[22]  A. Khir,et al.  Gene expression profiling in ethnic Malays with type 2 diabetes mellitus, with and without diabetic nephropathy. , 2011, Journal of nephrology.

[23]  S. Bessa,et al.  Impact of Nitric Oxide Synthase Glu298Asp Polymorphism on the Development of End-Stage Renal Disease in Type 2 Diabetic Egyptian Patients , 2011, Renal failure.

[24]  T. Ahluwalia,et al.  Common variants in CNDP1 and CNDP2, and risk of nephropathy in type 2 diabetes , 2011, Diabetologia.

[25]  Z. Rahimi,et al.  Interaction of eNOS polymorphism with MTHFR variants increase the risk of diabetic nephropathy and its progression in type 2 diabetes mellitus patients , 2011, Molecular and Cellular Biochemistry.

[26]  K. Santos,et al.  Association of eNOS gene polymorphisms with renal disease in Caucasians with type 2 diabetes. , 2011, Diabetes research and clinical practice.

[27]  Jae-Wook Song,et al.  Observational Studies: Cohort and Case-Control Studies , 2010, Plastic and reconstructive surgery.

[28]  K. Chia,et al.  Genetic variation at the SLC12A3 locus is unlikely to explain risk for advanced diabetic nephropathy in Caucasians with type 2 diabetes. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[29]  C. Forsblom,et al.  A Functional Polymorphism in the Manganese Superoxide Dismutase Gene and Diabetic Nephropathy , 2007, Diabetes.

[30]  R. Ferrell,et al.  Identifying genetic susceptibilities to diabetes-related complications among individuals at low risk of complications: An application of tree-structured survival analysis. , 2006, American journal of epidemiology.

[31]  D. Healy.  Case-control studies in the genomic era: a clinician's guide , 2006, The Lancet Neurology.

[32]  H. Shin,et al.  SLC12A3 (solute carrier family 12 member [sodium/chloride] 3) polymorphisms are associated with end-stage renal disease in diabetic nephropathy. , 2006, Diabetes.

[33]  E. Ritz,et al.  The in situ expression of interleukin-8 in the normal human kidney and in different morphological forms of glomerulonephritis. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[34]  Yusuke Nakamura,et al.  Association of solute carrier family 12 (sodium/chloride) member 3 with diabetic nephropathy, identified by genome-wide analyses of single nucleotide polymorphisms. , 2003, Diabetes.

[35]  J. Balligand,et al.  Hsp90 Ensures the Transition from the Early Ca2+-dependent to the Late Phosphorylation-dependent Activation of the Endothelial Nitric-oxide Synthase in Vascular Endothelial Growth Factor-exposed Endothelial Cells* , 2001, The Journal of Biological Chemistry.

[36]  J. Stephenson,et al.  Overview of study design in clinical epidemiology , 2000, Sexually transmitted infections.

[37]  A. Hipkiss,et al.  Pluripotent Protective Effects of Carnosine, a Naturally Occurring Dipeptidea , 1998, Annals of the New York Academy of Sciences.

[38]  A. Hipkiss,et al.  Carnosine protects proteins against methylglyoxal-mediated modifications. , 1998, Biochemical and biophysical research communications.

[39]  S. Scherer,et al.  Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. , 1993, The Journal of biological chemistry.

[40]  M. Bickel.  The role of interleukin-8 in inflammation and mechanisms of regulation. , 1993, Journal of periodontology.

[41]  Antonio Tugores,et al.  NOS3 rs1799983 and rs2070744 polymorphisms and their association with advanced chronic kidney disease and coronary heart disease in Canarian population with type 2 diabetes. , 2021, Acta endocrinologica.

[42]  W. Rabie,et al.  The Role of Endothelial Nitric Oxide Synthase Gene 4 a / b Polymorphism and its Interaction with eNOSG 894 T Variants in Egyptian Type 2 Diabetes Mellitus as a Risk Factor to Nephropathy , 2022 .